| scholarly article | Q13442814 |
| P50 | author | Serpil C. Erzurum | Q99561107 |
| Kewal Asosingh | Q128024264 | ||
| P2093 | author name string | Deborah A Meyers | |
| Weiling Xu | |||
| Carole Bennett | |||
| Kelly Weiss | |||
| Nicholas Wanner | |||
| Sean Kessler | |||
| Chris D Lauruschkat | |||
| Mario Alemagno | |||
| Matthew Frimel | |||
| P2860 | cites work | CCR3 is a target for age-related macular degeneration diagnosis and therapy | Q24338258 |
| Arginine metabolism: nitric oxide and beyond | Q24531285 | ||
| A major susceptibility gene for asthma maps to chromosome 14q24 | Q24612202 | ||
| S-nitrosothiol signaling in respiratory biology | Q24650433 | ||
| Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma | Q24675014 | ||
| Lung macrophages contribute to house dust mite driven airway remodeling via HIF-1α | Q27311214 | ||
| Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation | Q28587850 | ||
| Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program | Q30422401 | ||
| NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response | Q30454236 | ||
| Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation | Q33240235 | ||
| Redox control of asthma: molecular mechanisms and therapeutic opportunities | Q33668491 | ||
| Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program | Q33725032 | ||
| Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia | Q33774598 | ||
| Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death | Q33795136 | ||
| IL-17 contributes to angiogenesis in rheumatoid arthritis | Q33802908 | ||
| Roles of arginase variants, atopy, and ozone in childhood asthma | Q34034365 | ||
| Allergic asthma: influence of genetic and environmental factors | Q34204432 | ||
| IL-17 in severe asthma. Where do we stand? | Q34435370 | ||
| Genetic polymorphisms in arginase I and II and childhood asthma and atopy | Q34574103 | ||
| Dietary inorganic nitrate improves mitochondrial efficiency in humans. | Q34626699 | ||
| Regulatory haplotypes in ARG1 are associated with altered bronchodilator response | Q34665101 | ||
| Requirement for Inducible Nitric Oxide Synthase in Chronic Allergen Exposure-Induced Pulmonary Fibrosis but Not Inflammation | Q34796204 | ||
| Characterization of inducible nitric oxide synthase expression in human airway epithelium | Q34941225 | ||
| Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis | Q35095605 | ||
| Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects | Q35534318 | ||
| Eotaxins and CCR3 Receptor in Inflammatory and Allergic Skin Diseases: Therapeutical Implications | Q35560567 | ||
| Cellular metabolism and disease: what do metabolic outliers teach us? | Q35915928 | ||
| The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma | Q36131162 | ||
| Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. | Q36131723 | ||
| Airway remodeling contributes to the progressive loss of lung function in asthma: an overview | Q36256195 | ||
| Nitrate biosynthesis in man | Q36384530 | ||
| Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response. | Q36601063 | ||
| Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases | Q36629111 | ||
| Nascent endothelium initiates Th2 polarization of asthma | Q36717794 | ||
| Arginine metabolism: boundaries of our knowledge | Q36826863 | ||
| T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation | Q36973651 | ||
| Increased mitochondrial arginine metabolism supports bioenergetics in asthma | Q37042318 | ||
| L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity | Q37359052 | ||
| Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism | Q37378058 | ||
| Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies | Q37455692 | ||
| Translating NO biology into clinical advances: still searching for the right dictionary? | Q37485631 | ||
| Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity | Q37549832 | ||
| Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis | Q37585025 | ||
| Protumor vs antitumor functions of IL-17. | Q37600557 | ||
| The potential role of interleukin-17 in severe asthma | Q37902959 | ||
| Arginine metabolic endotypes related to asthma severity. | Q38695202 | ||
| Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer | Q39290909 | ||
| Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene | Q39457714 | ||
| Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis | Q40764411 | ||
| Nitric oxide and asthma | Q41148243 | ||
| The immunology of asthma | Q41673436 | ||
| L-arginine is a precursor for nitrate biosynthesis in humans | Q41768928 | ||
| Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response | Q43700576 | ||
| Decreased arginine bioavailability and increased serum arginase activity in asthma | Q44834866 | ||
| Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts | Q56998465 | ||
| Selective Inducible Nitric Oxide Synthase Inhibition Has No Effect on Allergen Challenge in Asthma | Q58864341 | ||
| Lung Homing of Endothelial Progenitor Cells in Humans with Asthma after Allergen Challenge | Q61892478 | ||
| Increased vascularity of the bronchial mucosa in mild asthma | Q73528703 | ||
| Bronchial angiogenesis in severe glucocorticoid-dependent asthma | Q73966635 | ||
| Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
| IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma | Q79675199 | ||
| Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma | Q80427980 | ||
| Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma | Q84007863 | ||
| Bioenergetic Differences in the Airway Epithelium of Lean Versus Obese Asthmatics Are Driven by Nitric Oxide and Reflected in Circulating Platelets | Q90875715 | ||
| P433 | issue | 2 | |
| P577 | publication date | 2020-01-30 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Arginine metabolic control of airway inflammation | |
| P478 | volume | 5 |
Search more.